CD8A and neoplasm: Results of this interaction include upregulated expression of caspases, CD95 (Fas) and secretion of CD95 ligand (Fas ligand), and TNF-related apoptosis-inducing ligand (TRAIL), and enhanced detection of tumor cells by CD8+ and CD4+ T cells.